Sanofi India Limited (BOM:500674)
India
· Delayed Price · Currency is INR | Market Cap | 116.92B |
| Revenue (ttm) | 28.23B |
| Net Income (ttm) | 4.60B |
| Shares Out | 23.03M |
| EPS (ttm) | 199.60 |
| PE Ratio | 22.04 |
| Forward PE | n/a |
| Dividend | 167.00 (3.29%) |
| Ex-Dividend Date | n/a |
| Volume | 1,060 |
| Average Volume | 738 |
| Open | 5,200.80 |
| Previous Close | 5,187.80 |
| Day's Range | 5,157.65 - 5,280.85 |
| 52-Week Range | 4,145.90 - 10,526.05 |
| Beta | 0.28 |
| RSI | 30.18 |
| Earnings Date | Feb 21, 2025 |
About Sanofi India
Sanofi India Limited manufactures and trades in drugs and pharmaceutical products in India, Singapore and internationally. The company provides pharmaceutical products in various therapeutic areas, such as diabetes, cardiology, thrombosis, infections, central nervous system, anti-infectives, epilepsy, allergy and vitamins, and minerals and supplements, as well as pain care and nutritional health under the Lantus, Toujeo, Clexane, Amaryl, Cardace, Glimepiride, Cetapin, Targocid, Frisium, Combiflam, DePura, Allegra, and Avil brands through indepe... [Read more]
Financial Performance
In 2023, Sanofi India's revenue was 28.51 billion, an increase of 2.92% compared to the previous year's 27.70 billion. Earnings were 6.03 billion, a decrease of -2.85%.
Financial StatementsNews
52 week low stocks today on January 21: MRF, Axis Bank, Sanofi India, Sterling, EaseMyTrip and more
On January 21, 2025, the Indian stock market saw a significant downturn, with both the BSE Sensex and Nifty 50 indices closing in the red. The BSE Sensex plunged 1,235.08 points, or 1.60%, finishing a...
Sanofi Consumer makes its debut on stock exchanges
Sanofi Consumer Healthcare has been listed on the BSE and NSE after its demerger from Sanofi India. Approved by the National Company Law Tribunal, this move aligns with Sanofi's global strategy. The c...